RVMD |
Revolution Medicines, Inc. |
Oct 8, 2024 |
1 |
-$250K |
4 |
Oct 10, 2024 |
Director |
RVMD |
Revolution Medicines, Inc. |
Aug 21, 2024 |
1 |
-$81.1K |
4 |
Aug 23, 2024 |
Director |
RVMD |
Revolution Medicines, Inc. |
Jun 20, 2024 |
2 |
$0 |
4/A |
Jun 28, 2024 |
Director |
RVMD |
Revolution Medicines, Inc. |
Jun 20, 2024 |
2 |
$0 |
4 |
Jun 24, 2024 |
Director |
TNGX |
Tango Therapeutics, Inc. |
Feb 6, 2024 |
2 |
-$115K |
4 |
Feb 8, 2024 |
Chief Executive Officer, Director |
TNGX |
Tango Therapeutics, Inc. |
Feb 1, 2024 |
2 |
$0 |
4 |
Feb 5, 2024 |
Chief Executive Officer, Director |
RVMD |
Revolution Medicines, Inc. |
Sep 1, 2023 |
5 |
-$469K |
4 |
Sep 6, 2023 |
Director |
RVMD |
Revolution Medicines, Inc. |
Jun 8, 2023 |
2 |
$0 |
4 |
Jun 12, 2023 |
Director |
TNGX |
Tango Therapeutics, Inc. |
Mar 1, 2023 |
2 |
$0 |
4 |
Mar 2, 2023 |
Chief Executive Officer, Director |
RVMD |
Revolution Medicines, Inc. |
Jun 16, 2022 |
2 |
$0 |
4 |
Jun 17, 2022 |
Director |
TNGX |
Tango Therapeutics, Inc. |
Feb 1, 2022 |
1 |
$0 |
4 |
Feb 3, 2022 |
Chief Executive Officer, Director |
OHAA |
Opy Acquisition Corp. I |
Oct 26, 2021 |
0 |
$0 |
3 |
Oct 27, 2021 |
Director |
TNGX |
Tango Therapeutics, Inc. |
Aug 12, 2021 |
1 |
$0 |
4 |
Aug 16, 2021 |
Chief Executive Officer, Director |
TNGX |
Tango Therapeutics, Inc. |
Aug 10, 2021 |
0 |
$0 |
3 |
Aug 12, 2021 |
Chief Executive Officer, Director |
RVMD |
Revolution Medicines, Inc. |
Jun 22, 2021 |
2 |
$0 |
4 |
Jun 24, 2021 |
Director |